Rayner Newsroom

Rayner announced today two events, jointly organised with St Thomas’s Hospital 
and the United Kingdom and Ireland Society of Cataract and Refractive Surgeons (UKISCRS) for Friday 8th September 2006.

The 2006 ASCRS meeting got off to a great start for Rayner with an important report from Prof. David Apple and Dr Guy Kleinman (Salt Lake City Utah, USA) on work carried out earlier this year on Rayner’s new small incision lens injector.

In a recently published article (Ocular Surgery News, January 2006) entitled “Continuous edge design inhibits cell migration on hydrophilic IOL”, Mr. Ashok Vyas, Scarborough, UK commented that the Rayner C-flex^® IOL (570C) provided a “barrier to lens epithelial cell migration, even at the optic-haptic junction, because of a ridge that encircled the entire periphery of the lens”.

At the XXIII Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) in Lisbon, Portugal, Rayner hosted two very well attended Satellite Meetings.

On Friday 9th September 2005, at the aptly named meeting, “We have the Edge – introducing the Rayner Multifocal”, delegates were not only introduced to Rayner’s new multifocal intraocular lens (M-flex®) but were also presented with the results from some new clinical studies for the C-flex® and Superflex^® intraocular lenses.

The Impact Foundation of Bangladesh recently reported on the work that it has done since Rayner started to regularly supply intraocular lenses to the Foundation. The lenses are used by Bangladesh and visiting surgeons from around the world such as recent visitors, Dr Bruce Munro from Geelong, Victoria, Australia and Mr Jim Haslam, Ophthalmic Surgeon from Darlington, UK.

UK implant manufacturer, Rayner Intraocular Lenses Ltd announced today that it had recently donated over a thousand intraocular lenses to the Bureau for the Prevention of Blindness, a division of the South Africa National Council for the Blind.

In a review of five years continuous experience of implanting Rayner’s Rayacryl^® lenses, surgeons Peter Bacon and Ashok Vyas from Scarborough Hospital, North Yorkshire, UK, jointly pronounce Rayner’s injectable lenses to be “very surgeon friendly” with an “excellent post-operative refraction accuracy”.

British IOL manufacturer, Rayner Intraocular Lenses Ltd., proudly announced today that it recently attained the coveted Therapeutic Goods Administration (TGA) clearance for sale of its intraocular lenses (IOLs) in Australia.

Rayner’s lenses are the first European IOLs to get TGA approval in over a decade. The TGA’s strict requirements over the years tended to restrict entry of new IOLs to Australia. This limited choice is about to change with Rayner’s entry into the market with the C-flex® injectable acrylic IOL system.

Rayner has recently produced an informative poster illustrating the anatomy of the eye. The poster is available to download as a PDF file.

Rayner (headquartered in the UK) announced today that the clinical investigation of the C-flex® injectable intraocular lens (IOL) system has started. Donald J. Munro, CEO of LA-based RAYNER SURGICAL INC., said that the study was, “well and truly underway” at all US and European sites. Mr Munro explained that the multi-site study will open the way for Rayner to supply US surgeons with a new technology lens that is already approved and widely used in Europe, Middle East, Asia, South America and South Africa.